Sutezolid (PNU-100480) exhibits excellent in vitro activity against multiple clinical isolates of Mycobacterium avium complex (MIC’s=0.5-4 µg/mL). MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Sutezolid (PNU-100480) is a thiomorpholinyl analog of linezolid with superior efficacy against M. tuberculosis in the hollow-fiber, mouse, and whole-blood models. MCE has not independently confirmed the accuracy of these methods. They are for reference only.